SCHEMBL448648

SCHEMBL448648

NS(=O)(=O)Cc1ccccc1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
TSHR P16473 1/20 0.56
HPGD P15428 1/20 0.51
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
MMP1 P03956 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46
MMP13 P45452 1/20 0.46
HTT P42858 1/20 0.44
CA5A P35218 1/20 0.44
CA9 Q16790 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
F2 P00734 1/20 0.42
PRSS1 P07477 1/20 0.42
PRSS2 P07478 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30297581 1.00 ALDH1A1 (0.56) ALDH1A1TSHRHPGDKMT2AMEN1
SCHEMBL28613032 0.85 ALDH1A1 (0.60) ALDH1A1TSHRHPGDKMT2AMEN1
SCHEMBL15657421 0.84 GPR35 (0.51) ALDH1A1TSHRHPGDKMT2AMEN1
SCHEMBL31628174 0.83 ALDH1A1 (0.58) ALDH1A1TSHRHPGDKMT2AMEN1
SCHEMBL9826058 0.83 ALDH1A1 (0.58) ALDH1A1TSHRHPGDKMT2AMEN1
SCHEMBL5481242 0.82 ALDH1A1 (0.53) ALDH1A1TSHRHPGDKMT2AMEN1
SCHEMBL4506185 0.81 ALDH1A1 (0.56) ALDH1A1TSHRHPGDKMT2AMEN1
SCHEMBL2398419 0.81 ALDH1A1 (0.56) ALDH1A1TSHRHPGDKMT2AMEN1
SCHEMBL270126 0.81 ALDH1A1 (0.61) ALDH1A1TSHRHPGDKMT2AMEN1
SCHEMBL31424902 0.81 ALDH1A1 (0.61) ALDH1A1TSHRHPGDKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7560460-B2 Substituted piperazines and methods of use AMGEN INC. (US) 2009-07-14 US claimed
EP-1417190-B1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEN INC (US) 2008-10-22 EP claimed
EP-1416933-B8 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEN INC (US) 2008-08-27 EP claimed
EP-1416933-B1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEM INC (US) 2008-01-02 EP claimed
US-20070265248-A1 Substituted piperazines and methods of use AMGEN INC. (US) 2007-11-15 US claimed
US-7115607-B2 Substituted piperazinyl amides and methods of use AMGEN INC. (US) 2006-10-03 US claimed
US-6977264-B2 Substituted piperidines and methods of use AMGEN INC. (US) 2005-12-20 US claimed
EP-1416933-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR Amgem, Inc. (US) 2004-05-12 EP claimed
EP-1417190-A1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR Amgen Inc. (US) 2004-05-12 EP claimed
US-20040006067-A1 Substituted piperidines and methods of use AMGEN INC. 2004-01-08 US claimed
US-20030220324-A1 Substituted piperazines and methods of use AMGEN INC. 2003-11-27 US claimed
WO-2003009847-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEM, INC. (US) 2003-02-06 WO claimed
WO-2003009850-A1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEN INC. (US) 2003-02-06 WO claimed
US-4260540-A SPIN DYEING POLYACRYLONITRILE BAYER AKTIENGESELLSCHAFT (DE) 1981-04-07 US claimed
US-4225489-A Heterocyclic azo dyes and pigments containing 4-quinazolinone moieties BAYER AKTIENGESELLSCHAFT (DE) 1980-09-30 US claimed
US-12303544-B2 Cytotoxic and anti-mitotic compounds, and methods of using the same ZYMEWORKS BC INC. (CA) 2025-05-20 US disclosed
US-20240287175-A1 COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED DISEASES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2024-08-29 US disclosed
US-4454334-A HERBICIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1984-06-12 US disclosed
US-4420325-A Herbicidal sulfonamides E. I. DU PONT DE NEMOURS & COMPANY (US) 1983-12-13 US disclosed
EP-0051466-A2 Herbicidal sulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1982-05-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220324-A1 Substituted piperazines and methods of use MC5R, MC4R, MC1R ALDH1A1 686/4885TSHR 271/4885HPGD 614/4885
US-20070265248-A1 Substituted piperazines and methods of use MC5R, MC4R, MC1R ALDH1A1 686/4885TSHR 271/4885HPGD 614/4885
US-12303544-B2 Cytotoxic and anti-mitotic compounds, and methods of using the same CCNB1, PLK1, BOD1L1 ALDH1A1 3393/4885TSHR 4613/4885HPGD 2608/4885
US-20040006067-A1 Substituted piperidines and methods of use MC4R, MC5R, MC1R ALDH1A1 423/4885TSHR 303/4885HPGD 608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.